The pharmaceutical company will fund transdermal and subcutaneous drug absorption model in GastroPlus. Simulations Plus chairman and chief executive officer Walt Woltosz said the funded collaboration will extend
The fund will increase the company’s effort to perfect its nanoparticle-based siRNA delivery systems and speed up the IND enabling studies for STP705. Sirnaomics has developed nanoparticle-based siRNA
Baxter has been given Orphan Drug Designation in the US as MMN is present between one or two people for approximately 100,000 individuals. The approval was based on
A total of 24 adult patients with type 2 diabetes, on insulin or oral agents, with a body mass index of 25-40kg/m² and with an A1C of less
Under the agreement, Ana Darou gained exclusive rights to market and sell Nalox/Emtrix in Iran while Moberg assumes production and supply responsibility. Moberg Derma CEO and founder Peter
Teduglutide, which is a novel, recombinant analogue of human glucagon-like peptide 2 (GLP-2), gained orphan drug designation for the treatment of SBS from the EMA and FDA. Takeda
The marketing authorization is valid in the current European Union Member States as well as in Iceland and Norway. AMAG president and chief executive officer William Heiden said
StartingPoint, with an expanded range of content templates and new capabilities supporting document creation and validation, provides predefined heading styles, fonts, margins and table formats to ensure a
Teva filed lawsuit against Momenta/Sandoz and Mylan/Natco for infringement of multiple patents covering the chemical composition of Copaxone, methods of using the product and processes for manufacturing the
The FDA has completed the review of the company’s investigational new drug application for Kevetrin. The Phase 1 trials were scheduled to be conducted at Harvard Cancer Center’s
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.